Merck & Co., Inc. (MRK)
Drug Manufacturers - General · Healthcare · $284.7B
Intrinsic Value (Consensus)
$81.72
Current Price
$115.17
Margin of Safety
-29%
29% Above Intrinsic Value
Value: $82
Price: $115
Valuation Model Estimates
Current Price: $115.17
DCF (Discounted Cash Flow)
$96.55
Graham Number
$58.63
Earnings Power Value
$70.68
Relative Value (P/E)
$145.60
Dividend Discount Model
$37.15
Consensus Value
$81.72
Model Assumptions
Discount Rate
10.3%
Growth Rate
8.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
67
Profitability
25/25
Strength
23/25
Valuation
9/25
Growth
10/25
Financial Health Signals
Strong profitability — ROE of 35% (above 20% is excellent)
Key Financials
- EPS (TTM)
- $7.28
- EPS (Forward)
- $7.86
- Book Value
- $20.98
- P/E Ratio
- 16.5
- Forward P/E
- 15.3
- PEG Ratio
- —
- ROE
- 34.7%
- Debt/Equity
- 34%
- Revenue Growth
- 1.3%
- Earnings Growth
- 8.0%
- Dividend Yield
- 0.7%
- Beta
- 0.22
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance